Relaxo Footwears faces a critical test in Q1 FY27 as it navigates the impact of a sharp intra-quarter polymer price spike against a backdrop of permanent wage increases. Investors will be looking for evidence that the company's 15-18% price hikes have successfully protected revenue growth without significantly dampening volume demand.
| Results date | August 13, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 751.10 Cr |
| Previous quarter PAT | Rs. 67.67 Cr |
| Previous quarter EBITDA margin | 16.5% |
| Market cap | Rs. 10,810.14 Cr |
| CMP | Rs. 434.25 |
The Board of Directors is scheduled to meet on Thursday, 13 August 2026, to consider and approve the unaudited financial results for the quarter ended 30 June 2026.
Revenue is likely to track ahead of the Q1 FY26 base of Rs. 654.49 Cr, supported by the full-year realization of 15-18% price hikes and sustained volume recovery momentum seen in Q4 FY26. While the company benefits from a large inventory buffer of approximately 184 days that likely shielded Q1 from the peak April polymer price spike, EBITDA margins are expected to face pressure YoY compared to the 15.2% level seen in Q1 FY26 due to the permanent 30% wage increase in Haryana. Management's commentary on the interplay between the April polymer surge and the subsequent easing of Brent crude to ~Rs. 70.50/bbl by late June will be central to understanding the margin trajectory for the remainder of the year. The upcoming call will likely focus on whether the volume demand of 4.3 Cr pairs recorded in Q1 FY26 has been maintained despite the significant price adjustments implemented across the portfolio.
Performance vs Guidance Tracking: Tracking progress against management's stated FY27 goals.
Volume and Price Sensitivity: Assessing consumer acceptance of recent price actions.
Input Cost and Margin Drivers: Evaluating the structural cost base and inventory impact.
Strategic and Operational Updates: Progress on long-term growth and efficiency initiatives.
In Q4 FY26, Relaxo reported revenue of Rs. 751.10 Cr and a PAT of Rs. 67.67 Cr. This performance reflected a recovery in volume growth and an EBITDA margin of 16.5%.
Management has guided for annual capex in the range of Rs. 100–150 Cr for FY27. This expenditure is focused on warehouse modernization, plant renovations, and EBO expansion, with no major capacity additions planned for the next 18 months.
The reduction of GST on footwear from 12% to 5% has leveled the playing field against unorganized players who previously held a tax advantage. Management expects this change to support market share gains and help the company return to its long-term growth trajectory.